title: Percutaneous transluminal coronary angioplasty and stent placement in pregnancy.
abstract: BACKGROUND
  Myocardial infarction (MI) is uncommon during pregnancy. As the average maternal age increases and assisted reproductive technology allows for very advanced maternal ages, so too may the incidence of MI during pregnancy. Percutaneous transluminal coronary angioplasty (PTCA) with stent placement is an attractive option for treatment of MI in pregnancy when revascularization is required.
  
  
  METHODS
  We present a gravida with an ST elevation MI during the third trimester, who was treated with emergent PTCA, stent placement, and platelet inhibitors, and we discuss the patient's subsequent obstetric and anesthetic management.
  
  
  CONCLUSIONS
  Percutaneous transluminal coronary angioplasty with stent placement may be used during the third trimester with successful outcome.
authors.affiliation: Department of Obstetrics, Stanford University, Stanford, California 94305, USA. dwyerb@stanford.edu
authors.forename: Bonnie K
authors.initials: BK
authors.lastname: Dwyer
authors.forename: Larisa
authors.initials: L
authors.lastname: Taylor
authors.forename: Andrea
authors.initials: A
authors.lastname: Fuller
authors.forename: Catherine
authors.initials: C
authors.lastname: Brummel
authors.forename: Deirdre J
authors.initials: DJ
authors.lastname: Lyell
mesh_terms: D000328:Adult; D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008423:Maternal Age; D009203:Myocardial Infarction / Q000150:complications / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000628:therapy*; D011256:Pregnancy Outcome; D011263:Pregnancy Trimester, Third; D015607:Stents
chemical_list: D010975:Platelet Aggregation Inhibitors